Search all news


3SBio Acquires Shanghai CP Guojian Pharmaceutical

Skadden represented 3SBio Inc. in its $214 million acquisition of Shanghai CP Guojian Pharmaceutical Co. Ltd.


Firm Earns Another Perfect Score on HRC Corporate Equality Index

The Human Rights Campaign Foundation again named Skadden one of the "Best Places to Work for LGBT Equality."


Pfizer and Allergan to Combine

Skadden is representing Pfizer Inc. in its combination with Allergan plc.


In Memoriam — Matthew Rosen

The firm mourns the death of our partner and friend Matthew Rosen.


Fidelity & Guaranty Life to Be Acquired by Anbang Insurance Group

Skadden is advising Fidelity & Guaranty Life on its acquisition by Anbang Insurance Group Co., Ltd. for $26.80 per share.


Plum Creek to Be Acquired by Weyerhaeuser Company

Skadden is advising Plum Creek Timber Co. Inc. on its $8.4 billion acquisition by Weyerhaeuser Company.


Darden Completes Spinoff of Four Corners Property Trust

Skadden represented Darden Restaurants, Inc. in the spinoff of select real estate and restaurant assets into Four Corners Property Trust, Inc.


Mindray Enters Into Agreement for Going-Private Transaction

Skadden is acting as U.S. legal adviser to the buyer group in the going-private transaction of China-based Mindray Medical International Limited.


2016 Chambers UK Guide Recognizes Skadden

Chambers UK has recognized 13 Skadden practices, 24 partners and three counsel in its 2016 guide. In Litigation, the firm was elevated from "Highly Regarded" to "Elite," the publication's highest Litigation bracket. Skadden also raised two tiers in Public International Law.


Skadden Receives 'Law Firm of the Year' Awards in Two Categories

Skadden was named the U.S. News — Best Lawyers "Law Firm of the Year" in both the Banking & Finance Law and the Commercial Litigation categories as part of the publication's 2016 "Best Law Firms" survey.